• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压或肾衰竭患者肾脏中尾加压素II相关肽及其受体的表达增加。

Increased expression of urotensin II-related peptide and its receptor in kidney with hypertension or renal failure.

作者信息

Mori Nobuyoshi, Hirose Takuo, Nakayama Takashi, Ito Osamu, Kanazawa Masayuki, Imai Yutaka, Kohzuki Masahiro, Takahashi Kazuhiro, Totsune Kazuhito

机构信息

Department of Internal Medicine and Rehabilitation Science, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.

出版信息

Peptides. 2009 Feb;30(2):400-8. doi: 10.1016/j.peptides.2008.09.021. Epub 2008 Oct 8.

DOI:10.1016/j.peptides.2008.09.021
PMID:18955095
Abstract

Urotensin II-related peptide (URP) is a novel vasoactive peptide that shares urotensin II receptor (UT) with urotensin II. In order to clarify possible changes of URP expression in hypertension and chronic renal failure (CRF), the expressions of URP and UT were studied by quantitative RT-PCR and immunohistochemistry in kidneys obtained from spontaneous hypertensive rats (SHR), Wistar-Kyoto rats (WKY), and WKY with CRF due to 5/6 nephrectomy. Expression levels of URP mRNA and UT mRNA were significantly higher in the kidneys obtained from SHR compared with age-matched WKY (at 5-16 and 16 weeks old, respectively). A dissection study of the kidney into three portions (inner medulla, outer medulla and cortex) showed that the expression levels of URP mRNA and UT mRNA were highest in the inner medulla and the outer medulla, respectively, in both SHR and WKY. The expression levels of URP and UT mRNAs were greatly elevated in the remnant kidneys of CRF rats at day 56 after nephrectomy, compared with sham-operated rats (about 6.5- and 11.9-fold, respectively). Immunohistochemistry showed that URP immunostaining was found mainly in the renal tubules, vascular smooth muscle cells and vascular endothelial cells. UT immunoreactivity was localized in the renal tubules and vascular endothelial cells. These findings suggest that the expressions of URP and UT mRNAs in the kidney are enhanced in hypertension and CRF, and that URP and its receptor have important pathophysiological roles in these diseases.

摘要

尾加压素 II 相关肽(URP)是一种新型血管活性肽,与尾加压素 II 共用尾加压素 II 受体(UT)。为了阐明高血压和慢性肾衰竭(CRF)中 URP 表达的可能变化,采用定量逆转录聚合酶链反应(RT-PCR)和免疫组织化学方法,研究了自发性高血压大鼠(SHR)、Wistar-Kyoto 大鼠(WKY)以及因 5/6 肾切除导致 CRF 的 WKY 大鼠肾脏中 URP 和 UT 的表达。与年龄匹配的 WKY 大鼠(分别在 5 - 16 周龄和 16 周龄时)相比,SHR 大鼠肾脏中 URP mRNA 和 UT mRNA 的表达水平显著更高。将肾脏分为三个部分(内髓质、外髓质和皮质)进行分析表明,在 SHR 和 WKY 大鼠中,URP mRNA 的表达水平在内髓质最高,而 UT mRNA 的表达水平在外髓质最高。肾切除术后第 56 天,与假手术大鼠相比,CRF 大鼠残余肾脏中 URP 和 UT mRNA 的表达水平大幅升高(分别约为 6.5 倍和 11.9 倍)。免疫组织化学显示,URP 免疫染色主要见于肾小管、血管平滑肌细胞和血管内皮细胞。UT 免疫反应性定位于肾小管和血管内皮细胞。这些发现表明,高血压和 CRF 时肾脏中 URP 和 UT mRNA 的表达增强,且 URP 及其受体在这些疾病中具有重要的病理生理作用。

相似文献

1
Increased expression of urotensin II-related peptide and its receptor in kidney with hypertension or renal failure.高血压或肾衰竭患者肾脏中尾加压素II相关肽及其受体的表达增加。
Peptides. 2009 Feb;30(2):400-8. doi: 10.1016/j.peptides.2008.09.021. Epub 2008 Oct 8.
2
Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.高血压大鼠心血管器官中尾加压素II、尾加压素II相关肽及尾加压素II受体mRNA表达增加:与内皮素-1的比较
Peptides. 2009 Jun;30(6):1124-9. doi: 10.1016/j.peptides.2009.02.009. Epub 2009 Feb 21.
3
Increased gene expression of urotensin II-related peptide in the hearts of rats with congestive heart failure.充血性心力衰竭大鼠心脏中尾加压素II相关肽的基因表达增加。
Peptides. 2008 May;29(5):801-8. doi: 10.1016/j.peptides.2007.12.018. Epub 2008 Jan 20.
4
Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.小鼠中尾加压素 II 的特性、尾加压素 II、尾加压素 II 相关肽及 UT 受体 mRNA 的分布:尾加压素 II 存在于神经肌肉接头处的证据
J Neurochem. 2008 Oct;107(2):361-74. doi: 10.1111/j.1471-4159.2008.05624.x. Epub 2008 Aug 14.
5
Enhanced renal sensitivity of the spontaneously hypertensive rat to urotensin II.自发性高血压大鼠对尾加压素II的肾敏感性增强。
Am J Physiol Renal Physiol. 2008 Oct;295(4):F1239-47. doi: 10.1152/ajprenal.90374.2008. Epub 2008 Aug 13.
6
Cellular distribution of the renal bumetanide-sensitive Na-K-2Cl cotransporter BSC-1 in the inner stripe of the outer medulla during the development of hypertension in the spontaneously hypertensive rat.自发性高血压大鼠高血压发展过程中外髓质内层布美他尼敏感的钠-钾-2氯协同转运体BSC-1在肾脏的细胞分布
Clin Exp Pharmacol Physiol. 2007 Dec;34(12):1307-12. doi: 10.1111/j.1440-1681.2007.04747.x.
7
[Expressions of urotensin II and its receptor in pulmonary arteries in rats with chronic thromboembolic pulmonary hypertension].[尾加压素II及其受体在慢性血栓栓塞性肺动脉高压大鼠肺动脉中的表达]
Zhonghua Jie He He Hu Xi Za Zhi. 2008 Jan;31(1):37-41.
8
Another ligand fishing for G protein-coupled receptor 14. Discovery of urotensin II-related peptide in the rat brain.另一种寻找G蛋白偶联受体14的配体。大鼠脑中尾加压素II相关肽的发现。
Peptides. 2008 May;29(5):809-12. doi: 10.1016/j.peptides.2007.06.005. Epub 2007 Jun 13.
9
Androgenic down-regulation of urotensin II precursor, urotensin II-related peptide precursor and androgen receptor mRNA in the mouse spinal cord.雄激素对小鼠脊髓中尾加压素II前体、尾加压素II相关肽前体及雄激素受体mRNA的下调作用。
Neuroscience. 2005;132(3):689-96. doi: 10.1016/j.neuroscience.2004.12.045.
10
Urotensin II-related peptide, the endogenous ligand for the urotensin II receptor in the rat brain.尾加压素II相关肽,大鼠脑中尾加压素II受体的内源性配体。
Peptides. 2004 Oct;25(10):1815-8. doi: 10.1016/j.peptides.2004.06.025.

引用本文的文献

1
Urotensin II system in chronic kidney disease.慢性肾脏病中的尾加压素II系统
Curr Res Physiol. 2024 May 7;7:100126. doi: 10.1016/j.crphys.2024.100126. eCollection 2024.
2
Genetic polymorphisms of rs2890565 Ser89Asn in coronary heart disease and myocardial infarction in Chinese population.中国人群中冠心病和心肌梗死相关的rs2890565基因多态性(Ser89Asn)
Int J Clin Exp Pathol. 2018 Apr 1;11(4):2125-2136. eCollection 2018.
3
Urotensin II in the development and progression of chronic kidney disease following ⅚ nephrectomy in the rat.
尾加压素II在大鼠⅚肾切除术后慢性肾脏病的发生与进展中的作用
Exp Physiol. 2019 Mar;104(3):421-433. doi: 10.1113/EP087366. Epub 2019 Jan 15.
4
The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.神经肽尾加压素II的G蛋白偶联受体UT具有结构和功能趋化因子特征。
Front Endocrinol (Lausanne). 2017 Apr 25;8:76. doi: 10.3389/fendo.2017.00076. eCollection 2017.
5
Plasma Urotensin II levels in children and adolescents with chronic kidney disease: a single-centre study.慢性肾脏病儿童及青少年的血浆尾加压素II水平:一项单中心研究
BMC Nephrol. 2017 Mar 31;18(1):113. doi: 10.1186/s12882-017-0530-9.
6
Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions.经皮冠状动脉介入治疗患者使用造影剂后尾加压素 - II和内皮素 - I水平
J Res Med Sci. 2013 Mar;18(3):205-9.
7
Urotensin II levels in patients with chronic kidney disease and kidney transplants.慢性肾脏病和肾移植患者的尾加压素 II 水平。
Ups J Med Sci. 2012 Mar;117(1):22-7. doi: 10.3109/03009734.2011.626541. Epub 2011 Nov 18.
8
Renal impairment, hypertension and plasma urotensin II.肾功能损害、高血压与血浆尾加压素Ⅱ。
Nephrol Dial Transplant. 2011 Feb;26(2):609-14. doi: 10.1093/ndt/gfq416. Epub 2010 Jul 9.